These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 38891760)

  • 1. Limb Girdle Muscular Dystrophy Type 2B (LGMD2B): Diagnosis and Therapeutic Possibilities.
    Poudel BH; Fletcher S; Wilton SD; Aung-Htut M
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translational research and therapeutic perspectives in dysferlinopathies.
    Barthélémy F; Wein N; Krahn M; Lévy N; Bartoli M
    Mol Med; 2011; 17(9-10):875-82. PubMed ID: 21556485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compound heterozygous DYSF variants causing limb-girdle muscular dystrophy type 2B in a Chinese family.
    Li L; Jing Z; Cheng L; Liu W; Wang H; Xu Y; Zheng X; Yu X; Liu S
    J Gene Med; 2020 Nov; 22(11):e3272. PubMed ID: 32889728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysferlinopathies: Clinical and genetic variability.
    Ivanova A; Smirnikhina S; Lavrov A
    Clin Genet; 2022 Dec; 102(6):465-473. PubMed ID: 36029111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic exon skipping for dysferlinopathies?
    Aartsma-Rus A; Singh KH; Fokkema IF; Ginjaar IB; van Ommen GJ; den Dunnen JT; van der Maarel SM
    Eur J Hum Genet; 2010 Aug; 18(8):889-94. PubMed ID: 20145676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Homozygous Variant in DYSF Gene Is Associated with Autosomal Recessive Limb Girdle Muscular Dystrophy R2/2B.
    Spadafora P; Qualtieri A; Cavalcanti F; Di Palma G; Gallo O; De Benedittis S; Cerantonio A; Citrigno L
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of pseudoexon splicing caused by a novel intronic dysferlin mutation.
    Dominov JA; Uyan Ö; McKenna-Yasek D; Nallamilli BRR; Kergourlay V; Bartoli M; Levy N; Hudson J; Evangelista T; Lochmuller H; Krahn M; Rufibach L; Hegde M; Brown RH
    Ann Clin Transl Neurol; 2019 Apr; 6(4):642-654. PubMed ID: 31019989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report of an adolescent girl with limb-girdle muscular dystrophy type 2B - the usefulness of muscle protein immunostaining in the diagnosis of dysferlinopathies.
    Szymanska S; Rokicki D; Karkucinska-Wieckowska A; Szymanska-Debinska T; Ciara E; Ploski R; Grajkowska W; Pronicki M
    Folia Neuropathol; 2014; 52(4):452-6. PubMed ID: 25574751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DYSF mutation analysis in a group of Chinese patients with dysferlinopathy.
    Zhao Z; Hu J; Sakiyama Y; Okamoto Y; Higuchi I; Li N; Shen H; Takashima H
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1234-7. PubMed ID: 23254335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limb-Girdle Muscular Dystrophy 2B and Miyoshi Presentations of Dysferlinopathy.
    Patel NJ; Van Dyke KW; Espinoza LR
    Am J Med Sci; 2017 May; 353(5):484-491. PubMed ID: 28502335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limb-girdle muscular dystrophy type 2B causes HDL-C abnormalities in patients and statin-resistant muscle wasting in dysferlin-deficient mice.
    White Z; Sun Z; Sauge E; Cox D; Donen G; Pechkovsky D; Straub V; Francis GA; Bernatchez P
    Skelet Muscle; 2022 Nov; 12(1):25. PubMed ID: 36447272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limb-girdle muscular dystrophy type 2B misdiagnosed as polymyositis at the early stage: Case report and literature review.
    Xu C; Chen J; Zhang Y; Li J
    Medicine (Baltimore); 2018 May; 97(21):e10539. PubMed ID: 29794729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysferlin mutations in LGMD2B, Miyoshi myopathy, and atypical dysferlinopathies.
    Nguyen K; Bassez G; Bernard R; Krahn M; Labelle V; Figarella-Branger D; Pouget J; Hammouda el H; Béroud C; Urtizberea A; Eymard B; Leturcq F; Lévy N
    Hum Mutat; 2005 Aug; 26(2):165. PubMed ID: 16010686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysferlin mutation analysis in a group of Italian patients with limb-girdle muscular dystrophy and Miyoshi myopathy.
    Kawabe K; Goto K; Nishino I; Angelini C; Hayashi YK
    Eur J Neurol; 2004 Oct; 11(10):657-61. PubMed ID: 15469449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New developments in exon skipping and splice modulation therapies for neuromuscular diseases.
    Touznik A; Lee JJ; Yokota T
    Expert Opin Biol Ther; 2014 Jun; 14(6):809-19. PubMed ID: 24620745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s).
    Weiler T; Bashir R; Anderson LV; Davison K; Moss JA; Britton S; Nylen E; Keers S; Vafiadaki E; Greenberg CR; Bushby CR; Wrogemann K
    Hum Mol Genet; 1999 May; 8(5):871-7. PubMed ID: 10196377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morpholino-Mediated Exons 28-29 Skipping of Dysferlin and Characterization of Multiexon-skipped Dysferlin using RT-PCR, Immunoblotting, and Membrane Wounding Assay.
    Anwar S; Yokota T
    Methods Mol Biol; 2023; 2587():183-196. PubMed ID: 36401031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing Effective Antisense Oligonucleotides for Exon Skipping.
    Shimo T; Maruyama R; Yokota T
    Methods Mol Biol; 2018; 1687():143-155. PubMed ID: 29067661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functions of Vertebrate Ferlins.
    Bulankina AV; Thoms S
    Cells; 2020 Feb; 9(3):. PubMed ID: 32106631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysferlin protein analysis in limb-girdle muscular dystrophies.
    Vainzof M; Anderson LV; McNally EM; Davis DB; Faulkner G; Valle G; Moreira ES; Pavanello RC; Passos-Bueno MR; Zatz M
    J Mol Neurosci; 2001 Aug; 17(1):71-80. PubMed ID: 11665864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.